廣弘控股(000529.SZ):增持期屆滿 控股股東及其一致行動人累計增持1.16%股份
格隆匯8月6日丨廣弘控股(000529.SZ)公佈,公司於近日接到控股股東廣弘資產及其一致行動人廣弘創業《關於增持廣弘控股股份計劃時間屆滿暨完成增持計劃的吿知函》,吿知函稱按照2021年2月5日函吿的增持計劃,廣弘資產屬下全資子公司廣弘創業通過深交所證券交易系統集中交易方式對廣弘控股股份進行了增持,截止2021年8月4日,廣弘資產及廣弘創投對廣弘控股實施增持計劃時間屆滿,增持計劃實施完成。
自2020年12月28日至2021年08月04日,廣弘創投以自有資金通過深交所證券交易系統累計增持廣弘控股股份676.8834萬股,佔廣弘控股總股本的1.16%,增持使用資金4190萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.